<?xml version="1.0" encoding="UTF-8"  standalone="no" ?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2007-04-03" modified="2024-10-02" version="199" xmlns="http://uniprot.org/uniprot">
  <accession>O00425</accession>
  <accession>A0A4Z5</accession>
  <accession>Q63HM0</accession>
  <accession>Q6MZZ2</accession>
  <accession>Q86VB1</accession>
  <name>IF2B3_HUMAN</name>
  <protein>
    <recommendedName>
      <fullName>Insulin-like growth factor 2 mRNA-binding protein 3</fullName>
      <shortName>IGF2 mRNA-binding protein 3</shortName>
      <shortName>IMP-3</shortName>
    </recommendedName>
    <alternativeName>
      <fullName>IGF-II mRNA-binding protein 3</fullName>
    </alternativeName>
    <alternativeName>
      <fullName>KH domain-containing protein overexpressed in cancer</fullName>
      <shortName>hKOC</shortName>
    </alternativeName>
    <alternativeName>
      <fullName>VICKZ family member 3</fullName>
    </alternativeName>
  </protein>
  <gene>
    <name type="primary">IGF2BP3</name>
    <name type="synonym">IMP3</name>
    <name type="synonym">KOC1</name>
    <name type="synonym">VICKZ3</name>
  </gene>
  <organism>
    <name type="scientific">Homo sapiens</name>
    <name type="common">Human</name>
    <dbReference type="NCBI Taxonomy" id="9606"/>
    <lineage>
      <taxon>Eukaryota</taxon>
      <taxon>Metazoa</taxon>
      <taxon>Chordata</taxon>
      <taxon>Craniata</taxon>
      <taxon>Vertebrata</taxon>
      <taxon>Euteleostomi</taxon>
      <taxon>Mammalia</taxon>
      <taxon>Eutheria</taxon>
      <taxon>Euarchontoglires</taxon>
      <taxon>Primates</taxon>
      <taxon>Haplorrhini</taxon>
      <taxon>Catarrhini</taxon>
      <taxon>Hominidae</taxon>
      <taxon>Homo</taxon>
    </lineage>
  </organism>
  <reference key="1">
    <citation type="journal article" date="1997" name="Oncogene" volume="14" first="2729" last="2733">
      <title>Cloning of a gene highly overexpressed in cancer coding for a novel KH-domain containing protein.</title>
      <authorList>
        <person name="Mueller-Pillasch F."/>
        <person name="Lacher U."/>
        <person name="Wallrapp C."/>
        <person name="Micha A."/>
        <person name="Zimmerhackl F."/>
        <person name="Hameister H."/>
        <person name="Varga G."/>
        <person name="Friess H."/>
        <person name="Buechler M."/>
        <person name="Beger H.G."/>
        <person name="Vila M.R."/>
        <person name="Adler G."/>
        <person name="Gress T.M."/>
      </authorList>
      <dbReference type="PubMed" id="9178771"/>
      <dbReference type="DOI" id="10.1038/sj.onc.1201110"/>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
    <scope>TISSUE SPECIFICITY</scope>
    <source>
      <tissue>Pancreas</tissue>
      <tissue>Pancreatic cancer</tissue>
    </source>
  </reference>
  <reference key="2">
    <citation type="journal article" date="2007" name="BMC Genomics" volume="8" first="399" last="399">
      <title>The full-ORF clone resource of the German cDNA consortium.</title>
      <authorList>
        <person name="Bechtel S."/>
        <person name="Rosenfelder H."/>
        <person name="Duda A."/>
        <person name="Schmidt C.P."/>
        <person name="Ernst U."/>
        <person name="Wellenreuther R."/>
        <person name="Mehrle A."/>
        <person name="Schuster C."/>
        <person name="Bahr A."/>
        <person name="Bloecker H."/>
        <person name="Heubner D."/>
        <person name="Hoerlein A."/>
        <person name="Michel G."/>
        <person name="Wedler H."/>
        <person name="Koehrer K."/>
        <person name="Ottenwaelder B."/>
        <person name="Poustka A."/>
        <person name="Wiemann S."/>
        <person name="Schupp I."/>
      </authorList>
      <dbReference type="PubMed" id="17974005"/>
      <dbReference type="DOI" id="10.1186/1471-2164-8-399"/>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2)</scope>
    <source>
      <tissue>Endometrial tumor</tissue>
    </source>
  </reference>
  <reference key="3">
    <citation type="journal article" date="2003" name="Nature" volume="424" first="157" last="164">
      <title>The DNA sequence of human chromosome 7.</title>
      <authorList>
        <person name="Hillier L.W."/>
        <person name="Fulton R.S."/>
        <person name="Fulton L.A."/>
        <person name="Graves T.A."/>
        <person name="Pepin K.H."/>
        <person name="Wagner-McPherson C."/>
        <person name="Layman D."/>
        <person name="Maas J."/>
        <person name="Jaeger S."/>
        <person name="Walker R."/>
        <person name="Wylie K."/>
        <person name="Sekhon M."/>
        <person name="Becker M.C."/>
        <person name="O'Laughlin M.D."/>
        <person name="Schaller M.E."/>
        <person name="Fewell G.A."/>
        <person name="Delehaunty K.D."/>
        <person name="Miner T.L."/>
        <person name="Nash W.E."/>
        <person name="Cordes M."/>
        <person name="Du H."/>
        <person name="Sun H."/>
        <person name="Edwards J."/>
        <person name="Bradshaw-Cordum H."/>
        <person name="Ali J."/>
        <person name="Andrews S."/>
        <person name="Isak A."/>
        <person name="Vanbrunt A."/>
        <person name="Nguyen C."/>
        <person name="Du F."/>
        <person name="Lamar B."/>
        <person name="Courtney L."/>
        <person name="Kalicki J."/>
        <person name="Ozersky P."/>
        <person name="Bielicki L."/>
        <person name="Scott K."/>
        <person name="Holmes A."/>
        <person name="Harkins R."/>
        <person name="Harris A."/>
        <person name="Strong C.M."/>
        <person name="Hou S."/>
        <person name="Tomlinson C."/>
        <person name="Dauphin-Kohlberg S."/>
        <person name="Kozlowicz-Reilly A."/>
        <person name="Leonard S."/>
        <person name="Rohlfing T."/>
        <person name="Rock S.M."/>
        <person name="Tin-Wollam A.-M."/>
        <person name="Abbott A."/>
        <person name="Minx P."/>
        <person name="Maupin R."/>
        <person name="Strowmatt C."/>
        <person name="Latreille P."/>
        <person name="Miller N."/>
        <person name="Johnson D."/>
        <person name="Murray J."/>
        <person name="Woessner J.P."/>
        <person name="Wendl M.C."/>
        <person name="Yang S.-P."/>
        <person name="Schultz B.R."/>
        <person name="Wallis J.W."/>
        <person name="Spieth J."/>
        <person name="Bieri T.A."/>
        <person name="Nelson J.O."/>
        <person name="Berkowicz N."/>
        <person name="Wohldmann P.E."/>
        <person name="Cook L.L."/>
        <person name="Hickenbotham M.T."/>
        <person name="Eldred J."/>
        <person name="Williams D."/>
        <person name="Bedell J.A."/>
        <person name="Mardis E.R."/>
        <person name="Clifton S.W."/>
        <person name="Chissoe S.L."/>
        <person name="Marra M.A."/>
        <person name="Raymond C."/>
        <person name="Haugen E."/>
        <person name="Gillett W."/>
        <person name="Zhou Y."/>
        <person name="James R."/>
        <person name="Phelps K."/>
        <person name="Iadanoto S."/>
        <person name="Bubb K."/>
        <person name="Simms E."/>
        <person name="Levy R."/>
        <person name="Clendenning J."/>
        <person name="Kaul R."/>
        <person name="Kent W.J."/>
        <person name="Furey T.S."/>
        <person name="Baertsch R.A."/>
        <person name="Brent M.R."/>
        <person name="Keibler E."/>
        <person name="Flicek P."/>
        <person name="Bork P."/>
        <person name="Suyama M."/>
        <person name="Bailey J.A."/>
        <person name="Portnoy M.E."/>
        <person name="Torrents D."/>
        <person name="Chinwalla A.T."/>
        <person name="Gish W.R."/>
        <person name="Eddy S.R."/>
        <person name="McPherson J.D."/>
        <person name="Olson M.V."/>
        <person name="Eichler E.E."/>
        <person name="Green E.D."/>
        <person name="Waterston R.H."/>
        <person name="Wilson R.K."/>
      </authorList>
      <dbReference type="PubMed" id="12853948"/>
      <dbReference type="DOI" id="10.1038/nature01782"/>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
  </reference>
  <reference key="4">
    <citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
      <title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
      <authorList>
        <consortium name="The MGC Project Team"/>
      </authorList>
      <dbReference type="PubMed" id="15489334"/>
      <dbReference type="DOI" id="10.1101/gr.2596504"/>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
    <source>
      <tissue>Eye</tissue>
    </source>
  </reference>
  <reference key="5">
    <citation type="journal article" date="1999" name="Mech. Dev." volume="88" first="95" last="99">
      <title>Expression of the highly conserved RNA binding protein KOC in embryogenesis.</title>
      <authorList>
        <person name="Mueller-Pillasch F."/>
        <person name="Pohl B."/>
        <person name="Wilda M."/>
        <person name="Lacher U."/>
        <person name="Beil M."/>
        <person name="Wallrapp C."/>
        <person name="Hameister H."/>
        <person name="Knoechel W."/>
        <person name="Adler G."/>
        <person name="Gress T.M."/>
      </authorList>
      <dbReference type="PubMed" id="10525192"/>
      <dbReference type="DOI" id="10.1016/s0925-4773(99)00160-4"/>
    </citation>
    <scope>TISSUE SPECIFICITY</scope>
  </reference>
  <reference key="6">
    <citation type="journal article" date="1999" name="Mol. Cell. Biol." volume="19" first="1262" last="1270">
      <title>A family of insulin-like growth factor II mRNA-binding proteins represses translation in late development.</title>
      <authorList>
        <person name="Nielsen J."/>
        <person name="Christiansen J."/>
        <person name="Lykke-Andersen J."/>
        <person name="Johnsen A.H."/>
        <person name="Wewer U.M."/>
        <person name="Nielsen F.C."/>
      </authorList>
      <dbReference type="PubMed" id="9891060"/>
      <dbReference type="DOI" id="10.1128/mcb.19.2.1262"/>
    </citation>
    <scope>GENE NOMENCLATURE</scope>
    <scope>SUBCELLULAR LOCATION</scope>
    <scope>TISSUE SPECIFICITY</scope>
    <scope>RNA-BINDING</scope>
  </reference>
  <reference key="7">
    <citation type="journal article" date="2001" name="Clin. Immunol." volume="100" first="149" last="156">
      <title>Autoimmune responses to mRNA binding proteins p62 and Koc in diverse malignancies.</title>
      <authorList>
        <person name="Zhang J.-Y."/>
        <person name="Chan E.K."/>
        <person name="Peng X.-X."/>
        <person name="Lu M."/>
        <person name="Wang X."/>
        <person name="Mueller F."/>
        <person name="Tan E.M."/>
      </authorList>
      <dbReference type="PubMed" id="11465943"/>
      <dbReference type="DOI" id="10.1006/clim.2001.5048"/>
    </citation>
    <scope>IDENTIFICATION AS A CARCINOMA ANTIGEN</scope>
  </reference>
  <reference key="8">
    <citation type="journal article" date="2002" name="J. Med. Genet." volume="39" first="575" last="581">
      <title>Characterisation of the growth regulating gene IMP3, a candidate for Silver-Russell syndrome.</title>
      <authorList>
        <person name="Monk D."/>
        <person name="Bentley L."/>
        <person name="Beechey C."/>
        <person name="Hitchins M."/>
        <person name="Peters J."/>
        <person name="Preece M.A."/>
        <person name="Stanier P."/>
        <person name="Moore G.E."/>
      </authorList>
      <dbReference type="PubMed" id="12161597"/>
      <dbReference type="DOI" id="10.1136/jmg.39.8.575"/>
    </citation>
    <scope>TISSUE SPECIFICITY</scope>
  </reference>
  <reference key="9">
    <citation type="journal article" date="2003" name="Biochem. J." volume="376" first="383" last="391">
      <title>Nuclear transit of human zipcode-binding protein IMP1.</title>
      <authorList>
        <person name="Nielsen J."/>
        <person name="Adolph S.K."/>
        <person name="Rajpert-De Meyts E."/>
        <person name="Lykke-Andersen J."/>
        <person name="Koch G."/>
        <person name="Christiansen J."/>
        <person name="Nielsen F.C."/>
      </authorList>
      <dbReference type="PubMed" id="12921532"/>
      <dbReference type="DOI" id="10.1042/bj20030943"/>
    </citation>
    <scope>SUBCELLULAR LOCATION</scope>
  </reference>
  <reference key="10">
    <citation type="journal article" date="2005" name="Biol. Cell" volume="97" first="87" last="96">
      <title>VICKZ proteins: a multi-talented family of regulatory RNA-binding proteins.</title>
      <authorList>
        <person name="Yisraeli J.K."/>
      </authorList>
      <dbReference type="PubMed" id="15601260"/>
      <dbReference type="DOI" id="10.1042/bc20040151"/>
    </citation>
    <scope>REVIEW</scope>
  </reference>
  <reference key="11">
    <citation type="journal article" date="2005" name="Diagn. Mol. Pathol." volume="29" first="188" last="195">
      <title>KOC (K homology domain containing protein overexpressed in cancer): a novel molecular marker that distinguishes between benign and malignant lesions of the pancreas.</title>
      <authorList>
        <person name="Yantiss R.K."/>
        <person name="Woda B.A."/>
        <person name="Fanger G.R."/>
        <person name="Kalos M."/>
        <person name="Whalen G.F."/>
        <person name="Tada H."/>
        <person name="Andersen D.K."/>
        <person name="Rock K.L."/>
        <person name="Dresser K."/>
      </authorList>
      <dbReference type="PubMed" id="15644775"/>
      <dbReference type="DOI" id="10.1097/01.pas.0000149688.98333.54"/>
    </citation>
    <scope>SUBCELLULAR LOCATION</scope>
    <scope>TISSUE SPECIFICITY</scope>
  </reference>
  <reference key="12">
    <citation type="journal article" date="2005" name="Reproduction" volume="130" first="203" last="212">
      <title>Expression of IGF-II mRNA-binding proteins (IMPs) in gonads and testicular cancer.</title>
      <authorList>
        <person name="Hammer N.A."/>
        <person name="Hansen T.O."/>
        <person name="Byskov A.G."/>
        <person name="Rajpert-De Meyts E."/>
        <person name="Groendahl M.L."/>
        <person name="Bredkjaer H.E."/>
        <person name="Wewer U.M."/>
        <person name="Christiansen J."/>
        <person name="Nielsen F.C."/>
      </authorList>
      <dbReference type="PubMed" id="16049158"/>
      <dbReference type="DOI" id="10.1530/rep.1.00664"/>
    </citation>
    <scope>SUBCELLULAR LOCATION</scope>
    <scope>TISSUE SPECIFICITY</scope>
  </reference>
  <reference key="13">
    <citation type="journal article" date="2006" name="EMBO J." volume="25" first="1456" last="1468">
      <title>RNA-binding IMPs promote cell adhesion and invadopodia formation.</title>
      <authorList>
        <person name="Vikesaa J."/>
        <person name="Hansen T.V."/>
        <person name="Joenson L."/>
        <person name="Borup R."/>
        <person name="Wewer U.M."/>
        <person name="Christiansen J."/>
        <person name="Nielsen F.C."/>
      </authorList>
      <dbReference type="PubMed" id="16541107"/>
      <dbReference type="DOI" id="10.1038/sj.emboj.7601039"/>
    </citation>
    <scope>FUNCTION</scope>
    <scope>RNA-BINDING</scope>
    <scope>SUBCELLULAR LOCATION</scope>
  </reference>
  <reference key="14">
    <citation type="journal article" date="2006" name="Lancet Oncol." volume="7" first="556" last="564">
      <title>Analysis of RNA-binding protein IMP3 to predict metastasis and prognosis of renal-cell carcinoma: a retrospective study.</title>
      <authorList>
        <person name="Jiang Z."/>
        <person name="Chu P.G."/>
        <person name="Woda B.A."/>
        <person name="Rock K.L."/>
        <person name="Liu Q."/>
        <person name="Hsieh C.-C."/>
        <person name="Li C."/>
        <person name="Chen W."/>
        <person name="Duan H.O."/>
        <person name="McDougal S."/>
        <person name="Wu C.-L."/>
      </authorList>
      <dbReference type="PubMed" id="16814207"/>
      <dbReference type="DOI" id="10.1016/s1470-2045(06)70732-x"/>
    </citation>
    <scope>SUBCELLULAR LOCATION</scope>
    <scope>TISSUE SPECIFICITY</scope>
  </reference>
  <reference key="15">
    <citation type="journal article" date="2007" name="Mod. Pathol." volume="20" first="242" last="247">
      <title>IMP3 is a novel biomarker for adenocarcinoma in situ of the uterine cervix: an immunohistochemical study in comparison with p16(INK4a) expression.</title>
      <authorList>
        <person name="Li C."/>
        <person name="Rock K.L."/>
        <person name="Woda B.A."/>
        <person name="Jiang Z."/>
        <person name="Fraire A.E."/>
        <person name="Dresser K."/>
      </authorList>
      <dbReference type="PubMed" id="17192788"/>
      <dbReference type="DOI" id="10.1038/modpathol.3800735"/>
    </citation>
    <scope>SUBCELLULAR LOCATION</scope>
    <scope>TISSUE SPECIFICITY</scope>
  </reference>
  <reference key="16">
    <citation type="journal article" date="2007" name="Mol. Cell. Proteomics" volume="6" first="798" last="811">
      <title>Molecular composition of IMP1 ribonucleoprotein granules.</title>
      <authorList>
        <person name="Joeson L."/>
        <person name="Vikesaa J."/>
        <person name="Krogh A."/>
        <person name="Nielsen L.K."/>
        <person name="Hansen T."/>
        <person name="Borup R."/>
        <person name="Johnsen A.H."/>
        <person name="Christiansen J."/>
        <person name="Nielsen F.C."/>
      </authorList>
      <dbReference type="PubMed" id="17289661"/>
      <dbReference type="DOI" id="10.1074/mcp.m600346-mcp200"/>
    </citation>
    <scope>INTERACTION WITH IGF2BP1</scope>
  </reference>
  <reference key="17">
    <citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
      <title>A quantitative atlas of mitotic phosphorylation.</title>
      <authorList>
        <person name="Dephoure N."/>
        <person name="Zhou C."/>
        <person name="Villen J."/>
        <person name="Beausoleil S.A."/>
        <person name="Bakalarski C.E."/>
        <person name="Elledge S.J."/>
        <person name="Gygi S.P."/>
      </authorList>
      <dbReference type="PubMed" id="18669648"/>
      <dbReference type="DOI" id="10.1073/pnas.0805139105"/>
    </citation>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
    <source>
      <tissue>Cervix carcinoma</tissue>
    </source>
  </reference>
  <reference key="18">
    <citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
      <title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
      <authorList>
        <person name="Mayya V."/>
        <person name="Lundgren D.H."/>
        <person name="Hwang S.-I."/>
        <person name="Rezaul K."/>
        <person name="Wu L."/>
        <person name="Eng J.K."/>
        <person name="Rodionov V."/>
        <person name="Han D.K."/>
      </authorList>
      <dbReference type="PubMed" id="19690332"/>
      <dbReference type="DOI" id="10.1126/scisignal.2000007"/>
    </citation>
    <scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-528</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
    <source>
      <tissue>Leukemic T-cell</tissue>
    </source>
  </reference>
  <reference key="19">
    <citation type="journal article" date="2010" name="Genes Dev." volume="24" first="148" last="158">
      <title>ZBP1 recognition of beta-actin zipcode induces RNA looping.</title>
      <authorList>
        <person name="Chao J.A."/>
        <person name="Patskovsky Y."/>
        <person name="Patel V."/>
        <person name="Levy M."/>
        <person name="Almo S.C."/>
        <person name="Singer R.H."/>
      </authorList>
      <dbReference type="PubMed" id="20080952"/>
      <dbReference type="DOI" id="10.1101/gad.1862910"/>
    </citation>
    <scope>RNA-BINDING</scope>
    <scope>DOMAIN</scope>
  </reference>
  <reference key="20">
    <citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
      <title>Initial characterization of the human central proteome.</title>
      <authorList>
        <person name="Burkard T.R."/>
        <person name="Planyavsky M."/>
        <person name="Kaupe I."/>
        <person name="Breitwieser F.P."/>
        <person name="Buerckstuemmer T."/>
        <person name="Bennett K.L."/>
        <person name="Superti-Furga G."/>
        <person name="Colinge J."/>
      </authorList>
      <dbReference type="PubMed" id="21269460"/>
      <dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
    </citation>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
  </reference>
  <reference key="21">
    <citation type="journal article" date="2011" name="Sci. Signal." volume="4" first="RS3" last="RS3">
      <title>System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.</title>
      <authorList>
        <person name="Rigbolt K.T."/>
        <person name="Prokhorova T.A."/>
        <person name="Akimov V."/>
        <person name="Henningsen J."/>
        <person name="Johansen P.T."/>
        <person name="Kratchmarova I."/>
        <person name="Kassem M."/>
        <person name="Mann M."/>
        <person name="Olsen J.V."/>
        <person name="Blagoev B."/>
      </authorList>
      <dbReference type="PubMed" id="21406692"/>
      <dbReference type="DOI" id="10.1126/scisignal.2001570"/>
    </citation>
    <scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-184 AND THR-528</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
  </reference>
  <reference key="22">
    <citation type="journal article" date="2013" name="Biol. Chem." volume="394" first="1077" last="1090">
      <title>Subcellular localization and RNP formation of IGF2BPs (IGF2 mRNA-binding proteins) is modulated by distinct RNA-binding domains.</title>
      <authorList>
        <person name="Wachter K."/>
        <person name="Kohn M."/>
        <person name="Stohr N."/>
        <person name="Huttelmaier S."/>
      </authorList>
      <dbReference type="PubMed" id="23640942"/>
      <dbReference type="DOI" id="10.1515/hsz-2013-0111"/>
    </citation>
    <scope>FUNCTION</scope>
    <scope>RNA-BINDING</scope>
    <scope>OLIGOMERIZATION</scope>
    <scope>INTERACTION WITH ELAVL1; DHX9 AND HNRNPU</scope>
    <scope>DOMAIN</scope>
    <scope>SUBCELLULAR LOCATION</scope>
    <scope>MUTAGENESIS OF LYS-213; LYS-294; 423-LYS-LYS-424 AND 505-LYS-GLY-506</scope>
  </reference>
  <reference key="23">
    <citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
      <title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
      <authorList>
        <person name="Zhou H."/>
        <person name="Di Palma S."/>
        <person name="Preisinger C."/>
        <person name="Peng M."/>
        <person name="Polat A.N."/>
        <person name="Heck A.J."/>
        <person name="Mohammed S."/>
      </authorList>
      <dbReference type="PubMed" id="23186163"/>
      <dbReference type="DOI" id="10.1021/pr300630k"/>
    </citation>
    <scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-528</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
    <source>
      <tissue>Cervix carcinoma</tissue>
      <tissue>Erythroleukemia</tissue>
    </source>
  </reference>
  <reference key="24">
    <citation type="journal article" date="2014" name="Nat. Struct. Mol. Biol." volume="21" first="927" last="936">
      <title>Uncovering global SUMOylation signaling networks in a site-specific manner.</title>
      <authorList>
        <person name="Hendriks I.A."/>
        <person name="D'Souza R.C."/>
        <person name="Yang B."/>
        <person name="Verlaan-de Vries M."/>
        <person name="Mann M."/>
        <person name="Vertegaal A.C."/>
      </authorList>
      <dbReference type="PubMed" id="25218447"/>
      <dbReference type="DOI" id="10.1038/nsmb.2890"/>
    </citation>
    <scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-475</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
  </reference>
  <reference key="25">
    <citation type="journal article" date="2015" name="Proteomics" volume="15" first="2519" last="2524">
      <title>N-terminome analysis of the human mitochondrial proteome.</title>
      <authorList>
        <person name="Vaca Jacome A.S."/>
        <person name="Rabilloud T."/>
        <person name="Schaeffer-Reiss C."/>
        <person name="Rompais M."/>
        <person name="Ayoub D."/>
        <person name="Lane L."/>
        <person name="Bairoch A."/>
        <person name="Van Dorsselaer A."/>
        <person name="Carapito C."/>
      </authorList>
      <dbReference type="PubMed" id="25944712"/>
      <dbReference type="DOI" id="10.1002/pmic.201400617"/>
    </citation>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
  </reference>
  <reference key="26">
    <citation type="journal article" date="2017" name="Nat. Struct. Mol. Biol." volume="24" first="325" last="336">
      <title>Site-specific mapping of the human SUMO proteome reveals co-modification with phosphorylation.</title>
      <authorList>
        <person name="Hendriks I.A."/>
        <person name="Lyon D."/>
        <person name="Young C."/>
        <person name="Jensen L.J."/>
        <person name="Vertegaal A.C."/>
        <person name="Nielsen M.L."/>
      </authorList>
      <dbReference type="PubMed" id="28112733"/>
      <dbReference type="DOI" id="10.1038/nsmb.3366"/>
    </citation>
    <scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-450 AND LYS-475</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
  </reference>
  <reference key="27">
    <citation type="journal article" date="2018" name="Nat. Cell Biol." volume="20" first="285" last="295">
      <title>Recognition of RNA N6-methyladenosine by IGF2BP proteins enhances mRNA stability and translation.</title>
      <authorList>
        <person name="Huang H."/>
        <person name="Weng H."/>
        <person name="Sun W."/>
        <person name="Qin X."/>
        <person name="Shi H."/>
        <person name="Wu H."/>
        <person name="Zhao B.S."/>
        <person name="Mesquita A."/>
        <person name="Liu C."/>
        <person name="Yuan C.L."/>
        <person name="Hu Y.C."/>
        <person name="Huettelmaier S."/>
        <person name="Skibbe J.R."/>
        <person name="Su R."/>
        <person name="Deng X."/>
        <person name="Dong L."/>
        <person name="Sun M."/>
        <person name="Li C."/>
        <person name="Nachtergaele S."/>
        <person name="Wang Y."/>
        <person name="Hu C."/>
        <person name="Ferchen K."/>
        <person name="Greis K.D."/>
        <person name="Jiang X."/>
        <person name="Wei M."/>
        <person name="Qu L."/>
        <person name="Guan J.L."/>
        <person name="He C."/>
        <person name="Yang J."/>
        <person name="Chen J."/>
      </authorList>
      <dbReference type="PubMed" id="29476152"/>
      <dbReference type="DOI" id="10.1038/s41556-018-0045-z"/>
    </citation>
    <scope>FUNCTION</scope>
    <scope>INTERACTION WITH ELAVL1; MATR3 AND PABPC1</scope>
    <scope>SUBCELLULAR LOCATION</scope>
    <scope>ROLE OF KH DOMAINS</scope>
    <scope>MUTAGENESIS OF LYS-213; LYS-294; 423-LYS-LYS-424 AND 505-LYS-GLY-506</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
  </reference>
  <reference key="28">
    <citation type="submission" date="2007-06" db="PDB data bank">
      <title>Solution structure of RNA binding domain in insulin-like growth factor 2 mRNA-binding protein 3.</title>
      <authorList>
        <consortium name="RIKEN structural genomics initiative (RSGI)"/>
      </authorList>
    </citation>
    <scope>STRUCTURE BY NMR OF 73-161</scope>
  </reference>
  <comment type="function">
    <text evidence="8 13 14">RNA-binding factor that may recruit target transcripts to cytoplasmic protein-RNA complexes (mRNPs). This transcript 'caging' into mRNPs allows mRNA transport and transient storage. It also modulates the rate and location at which target transcripts encounter the translational apparatus and shields them from endonuclease attacks or microRNA-mediated degradation. Preferentially binds to N6-methyladenosine (m6A)-containing mRNAs and increases their stability (PubMed:29476152). Binds to the 3'-UTR of CD44 mRNA and stabilizes it, hence promotes cell adhesion and invadopodia formation in cancer cells. Binds to beta-actin/ACTB and MYC transcripts. Increases MYC mRNA stability by binding to the coding region instability determinant (CRD) and binding is enhanced by m6A-modification of the CRD (PubMed:29476152). Binds to the 5'-UTR of the insulin-like growth factor 2 (IGF2) mRNAs.</text>
  </comment>
  <comment type="subunit">
    <text evidence="11 13 14">Can form homooligomers and heterooligomers with IGF2BP1 and IGF2BP3 in an RNA-dependent manner (PubMed:23640942). Interacts with IGF2BP1 (PubMed:17289661). Interacts with ELAVL1, DHX9, HNRNPU, MATR3 and PABPC1 (PubMed:23640942, PubMed:29476152).</text>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-1058566">
      <id>O00425</id>
    </interactant>
    <interactant intactId="EBI-1053596">
      <id>Q13627</id>
      <label>DYRK1A</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>3</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-1058566">
      <id>O00425</id>
    </interactant>
    <interactant intactId="EBI-946095">
      <id>Q15365</id>
      <label>PCBP1</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>3</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-1058566">
      <id>O00425</id>
    </interactant>
    <interactant intactId="EBI-372899">
      <id>Q13148</id>
      <label>TARDBP</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>6</experiments>
  </comment>
  <comment type="subcellular location">
    <subcellularLocation>
      <location>Nucleus</location>
    </subcellularLocation>
    <subcellularLocation>
      <location>Cytoplasm</location>
    </subcellularLocation>
    <subcellularLocation>
      <location evidence="14">Cytoplasm</location>
      <location evidence="14">P-body</location>
    </subcellularLocation>
    <subcellularLocation>
      <location evidence="14">Cytoplasm</location>
      <location evidence="14">Stress granule</location>
    </subcellularLocation>
    <text>Found in lamellipodia of the leading edge, in the perinuclear region, and beneath the plasma membrane. The subcytoplasmic localization is cell specific and regulated by cell contact and growth. Localized at the connecting piece and the tail of the spermatozoa. Colocalized with CD44 mRNA in RNP granules. In response to cellular stress, such as oxidative stress, recruited to stress granules.</text>
  </comment>
  <comment type="alternative products">
    <event type="alternative splicing"/>
    <isoform>
      <id>O00425-1</id>
      <name>1</name>
      <sequence type="displayed"/>
    </isoform>
    <isoform>
      <id>O00425-2</id>
      <name>2</name>
      <sequence type="described" ref="VSP_024172"/>
    </isoform>
  </comment>
  <comment type="tissue specificity">
    <text evidence="4 5 6 7 9 10 15 16">Expressed in fetal liver, fetal lung, fetal kidney, fetal thymus, fetal placenta, fetal follicles of ovary and gonocytes of testis, growing oocytes, spermatogonia and semen (at protein level). Expressed in cervix adenocarcinoma, in testicular, pancreatic and renal-cell carcinomas (at protein level). Expressed ubiquitously during fetal development at 8 and 14 weeks of gestation. Expressed in ovary, testis, brain, placenta, pancreatic cancer tissues and pancreatic cancer cell lines.</text>
  </comment>
  <comment type="domain">
    <text evidence="12 13 14">All KH domains contribute to binding to target mRNA. Domains KH3 and KH4 are the major RNA-binding modules, although KH1 and KH2 also contribute (PubMed:29476152). The KH domains are also required for RNA-dependent homo- and heterooligomerization. The integrity of KH domains seems not to be required for localization to stress granules.</text>
  </comment>
  <comment type="miscellaneous">
    <text>Autoantibodies against IGF2BP3 are detected in sera from some patients with a variety of carcinomas.</text>
  </comment>
  <comment type="similarity">
    <text evidence="18">Belongs to the RRM IMP/VICKZ family.</text>
  </comment>
  <dbReference type="EMBL" id="U76705">
    <property type="protein sequence ID" value="AAD09223.1"/>
    <property type="molecule type" value="mRNA"/>
  </dbReference>
  <dbReference type="EMBL" id="U97188">
    <property type="protein sequence ID" value="AAC35208.1"/>
    <property type="molecule type" value="mRNA"/>
  </dbReference>
  <dbReference type="EMBL" id="BX640800">
    <property type="protein sequence ID" value="CAE45883.1"/>
    <property type="molecule type" value="mRNA"/>
  </dbReference>
  <dbReference type="EMBL" id="BX648488">
    <property type="protein sequence ID" value="CAH56186.1"/>
    <property type="molecule type" value="mRNA"/>
  </dbReference>
  <dbReference type="EMBL" id="AC005082">
    <property type="status" value="NOT_ANNOTATED_CDS"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="AC021876">
    <property type="status" value="NOT_ANNOTATED_CDS"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="AC079780">
    <property type="status" value="NOT_ANNOTATED_CDS"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="BC065269">
    <property type="protein sequence ID" value="AAH65269.1"/>
    <property type="molecule type" value="mRNA"/>
  </dbReference>
  <dbReference type="CCDS" id="CCDS5382.1">
    <molecule id="O00425-1"/>
  </dbReference>
  <dbReference type="RefSeq" id="NP_006538.2">
    <molecule id="O00425-1"/>
    <property type="nucleotide sequence ID" value="NM_006547.2"/>
  </dbReference>
  <dbReference type="PDB" id="2E44">
    <property type="method" value="NMR"/>
    <property type="chains" value="A=73-161"/>
  </dbReference>
  <dbReference type="PDB" id="6FQ1">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="1.31 A"/>
    <property type="chains" value="A/B=1-161"/>
  </dbReference>
  <dbReference type="PDB" id="6FQR">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.10 A"/>
    <property type="chains" value="A/B=1-161"/>
  </dbReference>
  <dbReference type="PDB" id="6GQE">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.15 A"/>
    <property type="chains" value="A=192-355"/>
  </dbReference>
  <dbReference type="PDB" id="6GX6">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.00 A"/>
    <property type="chains" value="A=1-161"/>
  </dbReference>
  <dbReference type="PDBsum" id="2E44"/>
  <dbReference type="PDBsum" id="6FQ1"/>
  <dbReference type="PDBsum" id="6FQR"/>
  <dbReference type="PDBsum" id="6GQE"/>
  <dbReference type="PDBsum" id="6GX6"/>
  <dbReference type="AlphaFoldDB" id="O00425"/>
  <dbReference type="SMR" id="O00425"/>
  <dbReference type="BioGRID" id="115887">
    <property type="interactions" value="526"/>
  </dbReference>
  <dbReference type="CORUM" id="O00425"/>
  <dbReference type="DIP" id="DIP-44171N"/>
  <dbReference type="IntAct" id="O00425">
    <property type="interactions" value="187"/>
  </dbReference>
  <dbReference type="MINT" id="O00425"/>
  <dbReference type="STRING" id="9606.ENSP00000258729"/>
  <dbReference type="GlyGen" id="O00425">
    <property type="glycosylation" value="1 site, 1 O-linked glycan (1 site)"/>
  </dbReference>
  <dbReference type="iPTMnet" id="O00425"/>
  <dbReference type="MetOSite" id="O00425"/>
  <dbReference type="PhosphoSitePlus" id="O00425"/>
  <dbReference type="SwissPalm" id="O00425"/>
  <dbReference type="BioMuta" id="IGF2BP3"/>
  <dbReference type="jPOST" id="O00425"/>
  <dbReference type="MassIVE" id="O00425"/>
  <dbReference type="PaxDb" id="9606-ENSP00000258729"/>
  <dbReference type="PeptideAtlas" id="O00425"/>
  <dbReference type="ProteomicsDB" id="47882">
    <molecule id="O00425-1"/>
  </dbReference>
  <dbReference type="ProteomicsDB" id="47883">
    <molecule id="O00425-2"/>
  </dbReference>
  <dbReference type="Pumba" id="O00425"/>
  <dbReference type="Antibodypedia" id="1056">
    <property type="antibodies" value="499 antibodies from 40 providers"/>
  </dbReference>
  <dbReference type="DNASU" id="10643"/>
  <dbReference type="Ensembl" id="ENST00000258729.8">
    <molecule id="O00425-1"/>
    <property type="protein sequence ID" value="ENSP00000258729.3"/>
    <property type="gene ID" value="ENSG00000136231.14"/>
  </dbReference>
  <dbReference type="Ensembl" id="ENST00000619562.4">
    <molecule id="O00425-2"/>
    <property type="protein sequence ID" value="ENSP00000480267.1"/>
    <property type="gene ID" value="ENSG00000136231.14"/>
  </dbReference>
  <dbReference type="GeneID" id="10643"/>
  <dbReference type="KEGG" id="hsa:10643"/>
  <dbReference type="MANE-Select" id="ENST00000258729.8">
    <property type="protein sequence ID" value="ENSP00000258729.3"/>
    <property type="RefSeq nucleotide sequence ID" value="NM_006547.3"/>
    <property type="RefSeq protein sequence ID" value="NP_006538.2"/>
  </dbReference>
  <dbReference type="UCSC" id="uc003swf.4">
    <molecule id="O00425-1"/>
    <property type="organism name" value="human"/>
  </dbReference>
  <dbReference type="AGR" id="HGNC:28868"/>
  <dbReference type="CTD" id="10643"/>
  <dbReference type="DisGeNET" id="10643"/>
  <dbReference type="GeneCards" id="IGF2BP3"/>
  <dbReference type="HGNC" id="HGNC:28868">
    <property type="gene designation" value="IGF2BP3"/>
  </dbReference>
  <dbReference type="HPA" id="ENSG00000136231">
    <property type="expression patterns" value="Tissue enhanced (lymphoid tissue, placenta)"/>
  </dbReference>
  <dbReference type="MIM" id="608259">
    <property type="type" value="gene"/>
  </dbReference>
  <dbReference type="neXtProt" id="NX_O00425"/>
  <dbReference type="OpenTargets" id="ENSG00000136231"/>
  <dbReference type="PharmGKB" id="PA128394576"/>
  <dbReference type="VEuPathDB" id="HostDB:ENSG00000136231"/>
  <dbReference type="eggNOG" id="KOG2193">
    <property type="taxonomic scope" value="Eukaryota"/>
  </dbReference>
  <dbReference type="GeneTree" id="ENSGT00940000154957"/>
  <dbReference type="HOGENOM" id="CLU_020744_1_0_1"/>
  <dbReference type="InParanoid" id="O00425"/>
  <dbReference type="OMA" id="CPDEGWA"/>
  <dbReference type="OrthoDB" id="3035007at2759"/>
  <dbReference type="PhylomeDB" id="O00425"/>
  <dbReference type="TreeFam" id="TF320229"/>
  <dbReference type="PathwayCommons" id="O00425"/>
  <dbReference type="Reactome" id="R-HSA-428359">
    <property type="pathway name" value="Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA"/>
  </dbReference>
  <dbReference type="SignaLink" id="O00425"/>
  <dbReference type="BioGRID-ORCS" id="10643">
    <property type="hits" value="23 hits in 1172 CRISPR screens"/>
  </dbReference>
  <dbReference type="ChiTaRS" id="IGF2BP3">
    <property type="organism name" value="human"/>
  </dbReference>
  <dbReference type="EvolutionaryTrace" id="O00425"/>
  <dbReference type="GeneWiki" id="IGF2BP3"/>
  <dbReference type="GenomeRNAi" id="10643"/>
  <dbReference type="Pharos" id="O00425">
    <property type="development level" value="Tbio"/>
  </dbReference>
  <dbReference type="PRO" id="PR:O00425"/>
  <dbReference type="Proteomes" id="UP000005640">
    <property type="component" value="Chromosome 7"/>
  </dbReference>
  <dbReference type="RNAct" id="O00425">
    <property type="molecule type" value="protein"/>
  </dbReference>
  <dbReference type="Bgee" id="ENSG00000136231">
    <property type="expression patterns" value="Expressed in secondary oocyte and 134 other cell types or tissues"/>
  </dbReference>
  <dbReference type="ExpressionAtlas" id="O00425">
    <property type="expression patterns" value="baseline and differential"/>
  </dbReference>
  <dbReference type="GO" id="GO:0005737">
    <property type="term" value="C:cytoplasm"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="BHF-UCL"/>
  </dbReference>
  <dbReference type="GO" id="GO:0010494">
    <property type="term" value="C:cytoplasmic stress granule"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0005829">
    <property type="term" value="C:cytosol"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="HPA"/>
  </dbReference>
  <dbReference type="GO" id="GO:0005634">
    <property type="term" value="C:nucleus"/>
    <property type="evidence" value="ECO:0000318"/>
    <property type="project" value="GO_Central"/>
  </dbReference>
  <dbReference type="GO" id="GO:0000932">
    <property type="term" value="C:P-body"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0003730">
    <property type="term" value="F:mRNA 3'-UTR binding"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0048027">
    <property type="term" value="F:mRNA 5'-UTR binding"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="BHF-UCL"/>
  </dbReference>
  <dbReference type="GO" id="GO:1990247">
    <property type="term" value="F:N6-methyladenosine-containing RNA reader activity"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0003723">
    <property type="term" value="F:RNA binding"/>
    <property type="evidence" value="ECO:0007005"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0045182">
    <property type="term" value="F:translation regulator activity"/>
    <property type="evidence" value="ECO:0000250"/>
    <property type="project" value="BHF-UCL"/>
  </dbReference>
  <dbReference type="GO" id="GO:0009653">
    <property type="term" value="P:anatomical structure morphogenesis"/>
    <property type="evidence" value="ECO:0000304"/>
    <property type="project" value="ProtInc"/>
  </dbReference>
  <dbReference type="GO" id="GO:0070934">
    <property type="term" value="P:CRD-mediated mRNA stabilization"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0051028">
    <property type="term" value="P:mRNA transport"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="UniProtKB-KW"/>
  </dbReference>
  <dbReference type="GO" id="GO:0017148">
    <property type="term" value="P:negative regulation of translation"/>
    <property type="evidence" value="ECO:0000250"/>
    <property type="project" value="BHF-UCL"/>
  </dbReference>
  <dbReference type="GO" id="GO:0007399">
    <property type="term" value="P:nervous system development"/>
    <property type="evidence" value="ECO:0000318"/>
    <property type="project" value="GO_Central"/>
  </dbReference>
  <dbReference type="GO" id="GO:0001817">
    <property type="term" value="P:regulation of cytokine production"/>
    <property type="evidence" value="ECO:0000305"/>
    <property type="project" value="BHF-UCL"/>
  </dbReference>
  <dbReference type="GO" id="GO:0006412">
    <property type="term" value="P:translation"/>
    <property type="evidence" value="ECO:0000304"/>
    <property type="project" value="ProtInc"/>
  </dbReference>
  <dbReference type="CDD" id="cd22492">
    <property type="entry name" value="KH-I_IGF2BP3_rpt1"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="CDD" id="cd22498">
    <property type="entry name" value="KH-I_IGF2BP3_rpt3"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="CDD" id="cd12627">
    <property type="entry name" value="RRM1_IGF2BP3"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="CDD" id="cd12630">
    <property type="entry name" value="RRM2_IGF2BP3"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="Gene3D" id="3.30.310.210">
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="Gene3D" id="3.30.70.330">
    <property type="match status" value="2"/>
  </dbReference>
  <dbReference type="Gene3D" id="3.30.1370.10">
    <property type="entry name" value="K Homology domain, type 1"/>
    <property type="match status" value="2"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR004087">
    <property type="entry name" value="KH_dom"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR004088">
    <property type="entry name" value="KH_dom_type_1"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR036612">
    <property type="entry name" value="KH_dom_type_1_sf"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR012677">
    <property type="entry name" value="Nucleotide-bd_a/b_plait_sf"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR035979">
    <property type="entry name" value="RBD_domain_sf"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR000504">
    <property type="entry name" value="RRM_dom"/>
  </dbReference>
  <dbReference type="PANTHER" id="PTHR10288:SF158">
    <property type="entry name" value="INSULIN-LIKE GROWTH FACTOR 2 MRNA-BINDING PROTEIN 3"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="PANTHER" id="PTHR10288">
    <property type="entry name" value="KH DOMAIN CONTAINING RNA BINDING PROTEIN"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="Pfam" id="PF00013">
    <property type="entry name" value="KH_1"/>
    <property type="match status" value="4"/>
  </dbReference>
  <dbReference type="Pfam" id="PF00076">
    <property type="entry name" value="RRM_1"/>
    <property type="match status" value="2"/>
  </dbReference>
  <dbReference type="SMART" id="SM00322">
    <property type="entry name" value="KH"/>
    <property type="match status" value="4"/>
  </dbReference>
  <dbReference type="SMART" id="SM00360">
    <property type="entry name" value="RRM"/>
    <property type="match status" value="2"/>
  </dbReference>
  <dbReference type="SUPFAM" id="SSF54791">
    <property type="entry name" value="Eukaryotic type KH-domain (KH-domain type I)"/>
    <property type="match status" value="4"/>
  </dbReference>
  <dbReference type="SUPFAM" id="SSF54928">
    <property type="entry name" value="RNA-binding domain, RBD"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="PROSITE" id="PS50084">
    <property type="entry name" value="KH_TYPE_1"/>
    <property type="match status" value="4"/>
  </dbReference>
  <dbReference type="PROSITE" id="PS50102">
    <property type="entry name" value="RRM"/>
    <property type="match status" value="2"/>
  </dbReference>
  <proteinExistence type="evidence at protein level"/>
  <keyword id="KW-0002">3D-structure</keyword>
  <keyword id="KW-0025">Alternative splicing</keyword>
  <keyword id="KW-0963">Cytoplasm</keyword>
  <keyword id="KW-1017">Isopeptide bond</keyword>
  <keyword id="KW-0509">mRNA transport</keyword>
  <keyword id="KW-0539">Nucleus</keyword>
  <keyword id="KW-0597">Phosphoprotein</keyword>
  <keyword id="KW-1267">Proteomics identification</keyword>
  <keyword id="KW-1185">Reference proteome</keyword>
  <keyword id="KW-0677">Repeat</keyword>
  <keyword id="KW-0694">RNA-binding</keyword>
  <keyword id="KW-0810">Translation regulation</keyword>
  <keyword id="KW-0813">Transport</keyword>
  <keyword id="KW-0832">Ubl conjugation</keyword>
  <feature type="chain" id="PRO_0000282538" description="Insulin-like growth factor 2 mRNA-binding protein 3">
    <location>
      <begin position="1"/>
      <end position="579"/>
    </location>
  </feature>
  <feature type="domain" description="RRM 1" evidence="2">
    <location>
      <begin position="2"/>
      <end position="75"/>
    </location>
  </feature>
  <feature type="domain" description="RRM 2" evidence="2">
    <location>
      <begin position="81"/>
      <end position="156"/>
    </location>
  </feature>
  <feature type="domain" description="KH 1" evidence="1">
    <location>
      <begin position="195"/>
      <end position="260"/>
    </location>
  </feature>
  <feature type="domain" description="KH 2" evidence="1">
    <location>
      <begin position="276"/>
      <end position="343"/>
    </location>
  </feature>
  <feature type="domain" description="KH 3" evidence="1">
    <location>
      <begin position="405"/>
      <end position="470"/>
    </location>
  </feature>
  <feature type="domain" description="KH 4" evidence="1">
    <location>
      <begin position="487"/>
      <end position="553"/>
    </location>
  </feature>
  <feature type="region of interest" description="Disordered" evidence="3">
    <location>
      <begin position="160"/>
      <end position="192"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphoserine" evidence="20">
    <location>
      <position position="184"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphothreonine" evidence="19 20 21">
    <location>
      <position position="528"/>
    </location>
  </feature>
  <feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="23">
    <location>
      <position position="450"/>
    </location>
  </feature>
  <feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="22 23">
    <location>
      <position position="475"/>
    </location>
  </feature>
  <feature type="splice variant" id="VSP_024172" description="In isoform 2." evidence="17">
    <location>
      <begin position="1"/>
      <end position="381"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Partial reduction in interaction with m6A-modified mRNA; when associated with E-294. Loss of homo- and heterooligomerization with IGF2BP1 and IGF2BP2, modestly impaired binding to ACTB and MYC transcripts and almost no effect on ELAVL1-, DHX9- and HNRNPU-binding, nor on subcellular location; when associated with E-294; 422-E-E-423 and 505-E-E-506." evidence="13 14">
    <original>K</original>
    <variation>E</variation>
    <location>
      <position position="213"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Partial reduction in interaction with m6A-modified mRNA; when associated with E-213. Loss of homo- and heterooligomerization with IGF2BP1 and IGF2BP2, modestly impaired binding to ACTB and MYC transcripts and almost no effect on ELAVL1-, DHX9- and HNRNPU-binding, nor on subcellular location; when associated with E-213; 422-E-E-423 and 505-E-E-506." evidence="13 14">
    <original>K</original>
    <variation>E</variation>
    <location>
      <position position="294"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Loss of interaction with m6A-modified mRNA; when associated with 505-E-E-506. Loss of homo- and heterooligomerization with IGF2BP1 and IGF2BP2, modestly impaired binding to ACTB and MYC transcripts and almost no effect on ELAVL1-, DHX9- and HNRNPU-binding, nor on subcellular location; when associated with E-213; E-294 and 505-E-E-506." evidence="13 14">
    <original>KQ</original>
    <variation>EE</variation>
    <location>
      <begin position="423"/>
      <end position="424"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Loss of interaction with m6A-modified mRNA; when associated with 422-E-E-423. Loss of homo- and heterooligomerization with IGF2BP1 and IGF2BP2, modestly impaired binding to ACTB and MYC transcripts and almost no effect on ELAVL1-, DHX9- and HNRNPU-binding, nor on subcellular location; when associated with E-213; E-294 and 422-E-E-423." evidence="13 14">
    <original>KG</original>
    <variation>EE</variation>
    <location>
      <begin position="505"/>
      <end position="506"/>
    </location>
  </feature>
  <feature type="sequence conflict" description="In Ref. 1; AAD09223/AAC35208." evidence="18" ref="1">
    <original>L</original>
    <variation>Q</variation>
    <location>
      <position position="410"/>
    </location>
  </feature>
  <feature type="sequence conflict" description="In Ref. 2; CAH56186." evidence="18" ref="2">
    <original>V</original>
    <variation>A</variation>
    <location>
      <position position="494"/>
    </location>
  </feature>
  <feature type="strand" evidence="25">
    <location>
      <begin position="3"/>
      <end position="8"/>
    </location>
  </feature>
  <feature type="helix" evidence="25">
    <location>
      <begin position="15"/>
      <end position="24"/>
    </location>
  </feature>
  <feature type="strand" evidence="25">
    <location>
      <begin position="40"/>
      <end position="43"/>
    </location>
  </feature>
  <feature type="helix" evidence="25">
    <location>
      <begin position="47"/>
      <end position="57"/>
    </location>
  </feature>
  <feature type="turn" evidence="25">
    <location>
      <begin position="58"/>
      <end position="60"/>
    </location>
  </feature>
  <feature type="strand" evidence="26">
    <location>
      <begin position="61"/>
      <end position="63"/>
    </location>
  </feature>
  <feature type="strand" evidence="25">
    <location>
      <begin position="69"/>
      <end position="72"/>
    </location>
  </feature>
  <feature type="helix" evidence="25">
    <location>
      <begin position="76"/>
      <end position="78"/>
    </location>
  </feature>
  <feature type="strand" evidence="25">
    <location>
      <begin position="80"/>
      <end position="88"/>
    </location>
  </feature>
  <feature type="strand" evidence="24">
    <location>
      <begin position="90"/>
      <end position="92"/>
    </location>
  </feature>
  <feature type="helix" evidence="25">
    <location>
      <begin position="94"/>
      <end position="101"/>
    </location>
  </feature>
  <feature type="strand" evidence="25">
    <location>
      <begin position="107"/>
      <end position="112"/>
    </location>
  </feature>
  <feature type="strand" evidence="25">
    <location>
      <begin position="116"/>
      <end position="128"/>
    </location>
  </feature>
  <feature type="helix" evidence="25">
    <location>
      <begin position="129"/>
      <end position="139"/>
    </location>
  </feature>
  <feature type="strand" evidence="25">
    <location>
      <begin position="150"/>
      <end position="153"/>
    </location>
  </feature>
  <feature type="helix" evidence="25">
    <location>
      <begin position="157"/>
      <end position="159"/>
    </location>
  </feature>
  <evidence type="ECO:0000255" key="1">
    <source>
      <dbReference type="PROSITE-ProRule" id="PRU00117"/>
    </source>
  </evidence>
  <evidence type="ECO:0000255" key="2">
    <source>
      <dbReference type="PROSITE-ProRule" id="PRU00176"/>
    </source>
  </evidence>
  <evidence type="ECO:0000256" key="3">
    <source>
      <dbReference type="SAM" id="MobiDB-lite"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="4">
    <source>
      <dbReference type="PubMed" id="10525192"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="5">
    <source>
      <dbReference type="PubMed" id="12161597"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="6">
    <source>
      <dbReference type="PubMed" id="15644775"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="7">
    <source>
      <dbReference type="PubMed" id="16049158"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="8">
    <source>
      <dbReference type="PubMed" id="16541107"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="9">
    <source>
      <dbReference type="PubMed" id="16814207"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="10">
    <source>
      <dbReference type="PubMed" id="17192788"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="11">
    <source>
      <dbReference type="PubMed" id="17289661"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="12">
    <source>
      <dbReference type="PubMed" id="20080952"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="13">
    <source>
      <dbReference type="PubMed" id="23640942"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="14">
    <source>
      <dbReference type="PubMed" id="29476152"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="15">
    <source>
      <dbReference type="PubMed" id="9178771"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="16">
    <source>
      <dbReference type="PubMed" id="9891060"/>
    </source>
  </evidence>
  <evidence type="ECO:0000303" key="17">
    <source>
      <dbReference type="PubMed" id="17974005"/>
    </source>
  </evidence>
  <evidence type="ECO:0000305" key="18"/>
  <evidence type="ECO:0007744" key="19">
    <source>
      <dbReference type="PubMed" id="19690332"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="20">
    <source>
      <dbReference type="PubMed" id="21406692"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="21">
    <source>
      <dbReference type="PubMed" id="23186163"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="22">
    <source>
      <dbReference type="PubMed" id="25218447"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="23">
    <source>
      <dbReference type="PubMed" id="28112733"/>
    </source>
  </evidence>
  <evidence type="ECO:0007829" key="24">
    <source>
      <dbReference type="PDB" id="2E44"/>
    </source>
  </evidence>
  <evidence type="ECO:0007829" key="25">
    <source>
      <dbReference type="PDB" id="6FQ1"/>
    </source>
  </evidence>
  <evidence type="ECO:0007829" key="26">
    <source>
      <dbReference type="PDB" id="6GX6"/>
    </source>
  </evidence>
  <sequence length="579" mass="63705" checksum="78884F56A9D98CDE" modified="2009-07-28" version="2">MNKLYIGNLSENAAPSDLESIFKDAKIPVSGPFLVKTGYAFVDCPDESWALKAIEALSGKIELHGKPIEVEHSVPKRQRIRKLQIRNIPPHLQWEVLDSLLVQYGVVESCEQVNTDSETAVVNVTYSSKDQARQALDKLNGFQLENFTLKVAYIPDEMAAQQNPLQQPRGRRGLGQRGSSRQGSPGSVSKQKPCDLPLRLLVPTQFVGAIIGKEGATIRNITKQTQSKIDVHRKENAGAAEKSITILSTPEGTSAACKSILEIMHKEAQDIKFTEEIPLKILAHNNFVGRLIGKEGRNLKKIEQDTDTKITISPLQELTLYNPERTITVKGNVETCAKAEEEIMKKIRESYENDIASMNLQAHLIPGLNLNALGLFPPTSGMPPPTSGPPSAMTPPYPQFEQSETETVHLFIPALSVGAIIGKQGQHIKQLSRFAGASIKIAPAEAPDAKVRMVIITGPPEAQFKAQGRIYGKIKEENFVSPKEEVKLEAHIRVPSFAAGRVIGKGGKTVNELQNLSSAEVVVPRDQTPDENDQVVVKITGHFYACQVAQRKIQEILTQVKQHQQQKALQSGPPQSRRK</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>